Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Russell Chambers currently holds 149,061 shares of ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Russell Chambers has been a net buyer of HRT stock. They have purchased $296.9K and sold $44.2K worth of shares.
Jason Russell Chambers's most recent insider trade was on Nov 18, 2019, when they sold 2,472 shares at $2.36 per share.
Jason Russell Chambers serves as Executive at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT). They have executed 55 insider transactions totaling $341.2K over their tenure at the company.
Jason Russell Chambers holds the position of Executive at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Jason Russell Chambers has shown a buying trading pattern, with $296.9K in total purchases and $44.2K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jason Russell Chambers was on Dec 14, 2018, when they purchased $47.6K worth of MICR shares. This transaction involved 14,889 shares at $3.20 per share.
Jason Russell Chambers currently owns 149,061 shares of ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Russell Chambers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Russell Chambers has 55 Form 4 filings on record as an insider at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/.
Set alerts for Jason Russell Chambers and 40,000+ other insiders.